000 | 01053 a2200301 4500 | ||
---|---|---|---|
005 | 20250516042655.0 | ||
264 | 0 | _c20110708 | |
008 | 201107s 0 0 eng d | ||
022 | _a1107-0625 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSahin, I | |
245 | 0 | 0 |
_aBRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes? _h[electronic resource] |
260 |
_bJournal of B.U.ON. : official journal of the Balkan Union of Oncology _c |
||
300 |
_a184-5 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aBreast Neoplasms _xchemistry |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenes, BRCA1 |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aPhthalazines _xtherapeutic use |
650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
650 | 0 | 4 | _aPoly(ADP-ribose) Polymerase Inhibitors |
700 | 1 | _aArarat, E | |
700 | 1 | _aAltundag, K | |
773 | 0 |
_tJournal of B.U.ON. : official journal of the Balkan Union of Oncology _gvol. 16 _gno. 1 _gp. 184-5 |
|
999 |
_c20929801 _d20929801 |